Music has definitely played an impactful role in everyone's life. Listeners would resonate with most, if not all aspects of the song be it, the lyrics, the
Certara Appoints Dr Carol Gal - GuruFocus com gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.
CoIMMUNE: CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) CoImmune, Inc., a clinical stage immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the appointment of Dr. Edgardo Baracchini, to the Company s board of directors.
Dr. Baracchini brings a wealth of biotechnology industry and financial expertise, as well as significant prior board level experience, to the CoImmune board of directors. Dr. Baracchini has over 25 years of experience in structuring and negotiating research and development partnerships, mergers and acquisitions, and licensing agreements as a biotech industry executive. He has personally negotiated more than 80 business transactions with multinational pharmaceutical firms, biotechnology companies, and prominent universities. He has significant experience in alliance management, strategic planni
24 feb 2021
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) CoImmune, Inc., a clinical stage immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the appointment of Dr. Edgardo Baracchini, to the Company’s board of directors.
Dr. Baracchini brings a wealth of biotechnology industry and financial expertise, as well as significant prior board level experience, to the CoImmune board of directors. Dr. Baracchini has over 25 years of experience in structuring and negotiating research and development partnerships, mergers and acquisitions, and licensing agreements as a biotech industry executive. He has personally negotiated more than 80 business transactions with multinational pharmaceutical firms, biotechnology companies, and prominent universities. He has significant experience in alliance management, strategic p
Published: Feb 05, 2021
SAN DIEGO (BUSINESS WIRE) Today, Primmune Therapeutics announced the appointment of Rich Daniels as Chief Operating Officer, Scott Zook as Senior Vice President, Global Manufacturing and Randy Adams as Senior Advisor, Commercial Development.
“The appointments of Rich, Scott and Randy to the team build on the recent close of our Series A financing to support the development of PRTX007 as a therapeutic-adjuvant for viral diseases and cancer,” said Charlie McDermott, Chairman and Chief Executive Officer of Primmune Therapeutics. “Rich, Scott, and Randy have very deep domain experience in their respective functions and have taken multiple programs from early stage through global commercialization. In addition, they have been instrumental in the build out of successful startup organizations, thrived in large organizations, and are driven to address unmet medical needs with innovative therapeutics.”